Transduction and metabolic-driven Primary T-cell expansion in novel scalable bioreactors (2024)
Attributed to:
Miniaturisation of high throughput healthcare bioreactors for advanced therapeutics
funded by
UKRI FLF
Abstract
No abstract provided